Biliary tract involvement in autoimmune pancreatitis

Area of Science:

• Gastroenterology and Immunology
• Pathophysiology of Biliary Tract Diseases
• Autoimmune Disorders

Background:

• Autoimmune pancreatitis (AIP) is a distinct clinical condition.
• Biliary tract strictures are a common complication of AIP.
• Understanding the pathophysiology of biliary involvement is crucial for effective management.

Purpose of the Study:

• To investigate the pathophysiology of biliary tract involvement in autoimmune pancreatitis.
• To analyze clinicopathologic findings and response to treatment in AIP patients with biliary strictures.

Main Methods:

• Evaluation of 16 patients with AIP, including clinicopathologic findings.
• Histological and immunohistochemical examination of resected pancreatic, bile duct, and gallbladder tissues.
• Assessment of clinical and imaging data before and after prednisolone (PSL) therapy in 8 patients.

Main Results:

• 88% of AIP patients exhibited extrahepatic bile duct stricture; 94% showed bile duct wall thickening.
• Histology revealed lymphoplasmacytic infiltration and fibrosis in bile ducts and gallbladders, similar to pancreatic findings.
• Prednisolone therapy improved pancreatic inflammation but bile duct strictures persisted in 57% of affected patients.

Conclusions:

• Biliary involvement in AIP shares the same pathophysiologic mechanism as pancreatitis.
• CD8+/CD4+ T lymphocytes and IgG4-positive plasma cells are implicated in AIP pathogenesis.
• Targeting these immune cells may be key for treating AIP-related biliary complications.